Pharmaceutical compound
Clinical data | |
---|---|
Trade names | Fluonex, Lidex, others |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
MedlinePlus | a601054 |
Routes of administration | Topical |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Liver |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.005.998 |
Chemical and physical data | |
Formula | C26H32F2O7 |
Molar mass | 494.532 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
| |
(verify) |
Fluocinonide is a potent glucocorticoid used topically as an anti-inflammatory agent for the treatment of skin disorders such as eczema and seborrhoeic dermatitis. It relieves itching, redness, dryness, crusting, scaling, inflammation, and discomfort.
A common potential adverse effect is skin atrophy (thinning of the skin).
In 2022, it was the 266th most commonly prescribed medication in the United States, with more than 1 million prescriptions.
Veterinary uses
Fluocinonide is used in veterinary medicine. It is a treatment for allergies in dogs. Natural systemic cortisol concentrations can be suppressed for weeks after one week of topical exposure.
References
- "Fluocinonide Topical". MedlinePlus Drug Information. U.S. National Library of Medicine.
- "FDA-sourced list of all drugs with black box warnings (Use Download Full Results and View Query links.)". nctr-crs.fda.gov. FDA. Retrieved 22 October 2023.
- ^ "Fluocinonide Topical: MedlinePlus Drug Information". medlineplus.gov. Retrieved 16 November 2022.
- Jablonska S, Groniowska M, Dabroswki J (February 1979). "Comparative evaluation of skin atrophy in man induced by topical corticoids". The British Journal of Dermatology. 100 (2): 193–206. doi:10.1111/j.1365-2133.1979.tb05561.x. PMID 154921. S2CID 30656827.
- "The Top 300 of 2022". ClinCalc. Archived from the original on 30 August 2024. Retrieved 30 August 2024.
- "Fluocinonide Drug Usage Statistics, United States, 2013 - 2022". ClinCalc. Retrieved 30 August 2024.
- Dog Allergies. Squidoo (Report).
- Zenoble RD, Kemppainen RJ (September 1987). "Adrenocortical suppression by topically applied corticosteroids in healthy dogs". Journal of the American Veterinary Medical Association. 191 (6): 685–688. PMID 2824410.
Glucocorticoids and antiglucocorticoids (D07, H02) | |
---|---|
Glucocorticoids | |
Antiglucocorticoids |
|
Synthesis modifiers | |
|
Vasoprotectives (C05) | |||||||
---|---|---|---|---|---|---|---|
Antihemorrhoidals for topical use |
| ||||||
Antivaricose therapy |
| ||||||
Capillary stabilising agents |
|